Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes (vol 183, 109171, 2022)

Wang, YM; Li, HQ; Gao, H; Xu, XH; Cai, TT; Wang, HY; Zhou, YT; Huang, R; Su, XF; Ma, JH

Su, XF; Ma, JH (通讯作者),Nanjing Med Univ, Nanjing Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.

DIABETES RESEARCH AND CLINICAL PRACTICE, 2022; 190 ():